Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of the American Mosquito Control Association|January 25, 2003
Seasonal prevalence of Culex vishnui subgroup, the major vectors of Japanese encephalitis virus in an endemic district of Andhra Pradesh, IndiaU Suryanarayana Murty, D V R SatyaKumar, K Sriram, et al.
Parasitology Research|March 13, 2016
Can community-based integrated vector control hasten the process of LF elimination?I P Sunish, M Kalimuthu, V Ashok Kumar, et al.
Journal of Medical Entomology|June 6, 2009
Longitudinal studies of Japanese encephalitis virus infection in vector mosquitoes in Kurnool district, Andhra Pradesh, South IndiaN Arunachalam, U S N Murty, D Narahari, et al.
The Journal of Hospital Infection|August 14, 2019
Circulation of a community healthcare-associated multiply-resistant meticillin-resistant Staphylococcus aureus lineage in South Yorkshire identified by whole genome sequencingL Utsi, B Pichon, N Arunachalam, et al.
The Indian Journal of Medical Research|June 4, 2009
A study on chikungunya outbreak during 2007 in Kerala, south IndiaM Kannan, R Rajendran, I P Sunish, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 15, 2004
Japanese encephalitis virus (JEV) is an important cause of encephalitis among children in Cuddalore district, Tamil Nadu, IndiaLalitha Kabilan, Sudhanshu Vrati, Sudhansu Vrati, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2019
Design, synthesis and biological evaluation of phenol-linked uncialamycin antibody-drug conjugatesYam B Poudel, Chetana Rao, Srikanth Kotapati, et al.
Bioorganic & Medicinal Chemistry|February 10, 2018
Heterobicyclic inhibitors of transforming growth factor beta receptor I (TGFβRI)Lalgudi S Harikrishnan, Jayakumar Warrier, Andrew J Tebben, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative NeoplasmsHonghe Wan, Gretchen M Schroeder, Amy C Hart, et al.
Pageof 4